IN2012DN04381A - - Google Patents

Download PDF

Info

Publication number
IN2012DN04381A
IN2012DN04381A IN4381DEN2012A IN2012DN04381A IN 2012DN04381 A IN2012DN04381 A IN 2012DN04381A IN 4381DEN2012 A IN4381DEN2012 A IN 4381DEN2012A IN 2012DN04381 A IN2012DN04381 A IN 2012DN04381A
Authority
IN
India
Prior art keywords
acid sequence
melanoma
biomarkers
engrailed
diagnosis
Prior art date
Application number
Other languages
English (en)
Inventor
Richard Morgan
Hardev S Pandha
Original Assignee
Univ Surrey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Surrey filed Critical Univ Surrey
Publication of IN2012DN04381A publication Critical patent/IN2012DN04381A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IN4381DEN2012 2009-12-04 2010-07-13 IN2012DN04381A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0921329.9A GB0921329D0 (en) 2009-12-04 2009-12-04 Biomarker
PCT/GB2010/001334 WO2011067549A1 (en) 2009-12-04 2010-07-13 Melanoma specific biomarker

Publications (1)

Publication Number Publication Date
IN2012DN04381A true IN2012DN04381A (es) 2015-08-07

Family

ID=41641989

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4381DEN2012 IN2012DN04381A (es) 2009-12-04 2010-07-13

Country Status (14)

Country Link
US (1) US20120263654A1 (es)
EP (1) EP2507384A1 (es)
JP (1) JP2013512668A (es)
CN (1) CN102791878A (es)
AU (1) AU2010326433A1 (es)
BR (1) BR112012013041A2 (es)
CA (1) CA2782034A1 (es)
GB (1) GB0921329D0 (es)
IL (1) IL219834A0 (es)
IN (1) IN2012DN04381A (es)
MX (1) MX2012006229A (es)
RU (1) RU2012121096A (es)
WO (1) WO2011067549A1 (es)
ZA (1) ZA201203517B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011520451A (ja) 2008-05-14 2011-07-21 ダームテック インターナショナル 核酸解析による黒色腫および日光黒子の診断法
US20150005184A1 (en) * 2013-06-28 2015-01-01 Dermtech International Diagnosis of melanoma by nucleic acid analysis
WO2016168174A1 (en) * 2015-04-13 2016-10-20 The Translational Genomics Research Institute Predicting the occurrence of metastatic cancer using epigenomic biomarkers and non-invasive methodologies
JP2018518992A (ja) * 2015-06-24 2018-07-19 オックスフォード バイオダイナミックス リミテッド 染色体相互作用の部位を用いた検出法
US11976332B2 (en) 2018-02-14 2024-05-07 Dermtech, Inc. Gene classifiers and uses thereof in non-melanoma skin cancers
EP3948290A4 (en) 2019-03-26 2023-08-09 Dermtech, Inc. NEW GENE CLASSIFIERS AND THEIR USES FOR SKIN CANCERS
RU2766739C1 (ru) * 2021-04-12 2022-03-15 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Блохина" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ онкологии им. Н.Н. Блохина" Минздрава России) Способ прогноза эффективности терапии меланомы

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2469089A1 (en) * 2003-07-08 2005-01-08 Institut De Recherches Cliniques De Montreal En-2 gene, disgnostic and therapeutic uses thereof
US20070154889A1 (en) * 2004-06-25 2007-07-05 Veridex, Llc Methods and reagents for the detection of melanoma
US7615349B2 (en) * 2006-09-07 2009-11-10 H. Lee Moffitt Cancer Center And Research Institute, Inc. Melanoma gene signature
US7960110B2 (en) * 2006-11-15 2011-06-14 The Regents Of The University Of California Detection of chromosomal region copy number changes to diagnose melanoma
GB0625321D0 (en) * 2006-12-19 2007-01-24 Univ Surrey Cancer biomarker
WO2009131733A1 (en) * 2008-04-21 2009-10-29 The Trustees Of Columbia University In The City Of New York Gab2 amplification in melanoma

Also Published As

Publication number Publication date
ZA201203517B (en) 2013-02-27
IL219834A0 (en) 2012-07-31
CA2782034A1 (en) 2011-06-09
AU2010326433A1 (en) 2012-06-07
EP2507384A1 (en) 2012-10-10
GB0921329D0 (en) 2010-01-20
BR112012013041A2 (pt) 2016-10-11
RU2012121096A (ru) 2014-01-10
MX2012006229A (es) 2012-06-19
WO2011067549A1 (en) 2011-06-09
US20120263654A1 (en) 2012-10-18
JP2013512668A (ja) 2013-04-18
CN102791878A (zh) 2012-11-21

Similar Documents

Publication Publication Date Title
IN2012DN04381A (es)
WO2012054639A3 (en) Nmr systems and methods for the rapid detection of analytes
ZA200904684B (en) Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them
IL190796A (en) Composition containing nucleic acid encoded by anti-osteoclastogenic protein
WO2012069655A3 (en) Improved capping modules for designed ankyrin repeat proteins
EP1888786A4 (en) USE FREE CIRCULATIVE DNA FOR THE DIAGNOSIS, FORECAST AND TREATMENT OF CANCER
EP2179037A4 (en) DIAGNOSIS, FORECASTING AND TREATMENT PROCEDURES
WO2011137320A3 (en) Small molecule inhibitors of usp1 deubiquitinating enzyme activity
IL206975A (en) Enzyme n- Acetylgalactosamine-6-purified human recombinant sulfate and its uses
WO2011022667A3 (en) Catalytic domains from lysyl oxidase and loxl2
WO2010096604A3 (en) Uses of cancer-targeting peptides in cancer diagnosis
WO2011015944A3 (en) Use of free dna as an early predictor of severity in acute pancreatitis
WO2010132370A3 (en) Soluble tlt-1 for the treatment and diagnosis of sepsis
PL2086576T3 (pl) Białka H5, cząsteczki kwasu nukleinowego i wektory je kodujące oraz ich zastosowanie terapeutyczne
IL223076A0 (en) Novel as160-like protein, test systems, methods and uses involving it for the identification of diabetes type 2 therapeutics
WO2010115745A3 (en) Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis
MX2011004483A (es) Leucolectinas y sus usos.
EP1973945A4 (en) NEW NUCLEOTIDE AND AMINO ACID SEQUENCES AND METHOD FOR THEIR APPLICATION IN DIAGNOSIS
MY155340A (en) Use of cathepsin c
MX343251B (es) Biomarcador.
MX2012000558A (es) Biomarcador.
WO2008148932A3 (en) Glycosylasparaginase for treatment of cancers or inflammatory diseases
WO2011085134A8 (en) Methods and compositions for the diagnosis, prognosis and treatment of cancer
WO2009135953A3 (en) Amino acid sequences directed against integrins and uses thereof
WO2008008487A3 (en) Gene expression profiling for identification, monitoring and treatment of multiple sclerosis